ENTITY
Kyowa Kirin Co Ltd

Kyowa Kirin Co Ltd (4151 JP)

46
Analysis
Health CareJapan
Kyowa Hakko Kirin Co.,Ltd. develops, manufactures, and markets pharmaceuticals. The Company's products include a protein produced by genetic recombination technology, an anti-anemia agent that attaches new sugar chains through partial modification of the amino acid sequence of human erythropoietin (EPO), and a glycoprotein, human erythropoietin.
more
bearishKirin Holdings
04 Mar 2021 20:07

Norges Bank Puts Kirin On a Watchlist Over Ties with Myanmar Military Linked JV

We believe the market has already factored in the worst-case scenario for Kirin. That said, The Norges Bank putting Kirin on a watchlist could...

Logo
384 Views
Share
08 Sep 2020 13:02
Logo
330 Views
Share
05 Sep 2020 06:00

Asia Short Interest Weekly: Tencent, SMIC, Meituan, Galaxy, Kao, Sumitomo, Alteogen, Genius, Largan

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
352 Views
Share
bullishFancl Corp
06 Aug 2019 20:56

Fancl: Explanatory Meeting On Kirin's Stake Acquisition Light on Details but Stay Positive Anyway

At about 3:30pm JST news broke that Kirin Holdings (2503 JP) would acquire a 30.3% stake in Fancl Corp (4921 JP) from the company's founder and his...

Logo
Mio Kato
533 Views
Share
12 May 2019 18:41

🇯🇵 Japan • Spring Results & Revisions & Market Update - Slip-Slidin' Away

SLIP-SLIDIN' AWAY - Japanese equities have lost 3.9% in the last holiday-shortened week and 4.6% or ¥30t since the bear-market rally peak on 17th...

Logo
501 Views
Share
x